Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | BACE1 | P56817 | 2/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6317684 | 0.91 | ALDH1A1 (0.41) | ALDH1A1BACE1HSD11B1OPRM1OPRK1 | |
| SCHEMBL440388 | 0.90 | ALDH1A1 (0.40) | ALDH1A1BACE1HSD11B1OPRM1OPRK1 | |
| SCHEMBL444597 | 0.82 | ALDH1A1 (0.38) | ALDH1A1BACE1HSD11B1OPRM1OPRK1 | |
| SCHEMBL10170130 | 0.79 | OPRM1 (0.45) | ALDH1A1BACE1OPRM1OPRK1OPRL1 | |
| SCHEMBL5343015 | 0.78 | ALDH1A1 (0.39) | ALDH1A1BACE1MEN1KMT2AKCNH2 | |
| SCHEMBL3389800 | 0.77 | ALDH1A1 (0.43) | ALDH1A1HSD11B1OPRM1OPRK1OPRL1 | |
| SCHEMBL14369406 | 0.75 | OPRM1 (0.43) | ALDH1A1HSD11B1OPRM1OPRL1MEN1 | |
| SCHEMBL5343075 | 0.75 | APLNR (0.44) | BACE1HSD11B1MEN1KMT2ACYP2D6 | |
| SCHEMBL440389 | 0.72 | ALDH1A1 (0.40) | ALDH1A1OPRM1OPRK1OPRL1DRD4 | |
| SCHEMBL6304953 | 0.70 | CHRNB2 (0.36) | ALDH1A1BACE1HSD11B1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6239226-B1 | Block copolymers | BASF AKTIENGESELLSHCAFT (DE) | 2001-05-29 | — | — | US | claimed |
| EP-1964862-B1 | Composition and method for preparing linear copolymers of polar and non-polar olefins free of free radical initiated polymer | ROHM & HAAS (US) | 2010-12-22 | — | — | EP | disclosed |
| EP-1964862-A1 | Composition and method for preparing linear copolymers of polar and non-polar olefins absent free radical addition polymer | Rohm and Haas Company (US) | 2008-09-03 | — | — | EP | disclosed |
| US-6916893-B2 | Polymerization-active transition metal complexes having bulky ligand systems | SER. V. GMBH (DE) | 2005-07-12 | — | — | US | disclosed |
| US-20040171774-A1 | Polymerization-active transition metal complexes having bulky ligand systems | RIEGER BERNHARD (DE) | 2004-09-02 | — | — | US | disclosed |
| EP-1242434-B1 | POLYMERIZATION-ACTIVE TRANSITION METAL COMPLEX COMPOUNDS COMPRISING A STERICALLY DEMANDING LIGAND SYSTEM | SER V GMBH (DE) | 2004-06-02 | — | — | EP | disclosed |
| EP-1398330-A2 | Transition metal complexes having a bulky ligand system used in polymerisation | Ser.V. GmbH (DE) | 2004-03-17 | — | — | EP | disclosed |
| EP-1054913-B1 | METHOD FOR THE PRODUCTION OF POLYMERS FROM N-VINYL COMPOUNDS | BASF AG (DE) | 2003-04-23 | — | — | EP | disclosed |
| EP-0876404-B1 | PROCESS FOR PREPARING AN AQUEOUS POLYMER DISPERSION BY THE METHOD OF RADICAL AQUEOUS EMULSION POLYMERIZATION | BASF AG (DE) | 2003-04-09 | — | — | EP | disclosed |
| EP-1192197-B1 | METHOD FOR PRODUCING GRAFT COPOLYMERS, CONTAINING AN ELASTIC GRAFT COPOLYMER BACKBONE | BASF AG (DE) | 2002-12-04 | — | — | EP | disclosed |
| US-6239226-B1 | Block copolymers | BASF AKTIENGESELLSHCAFT (DE) | 2001-05-29 | — | — | US | disclosed |
| EP-0925311-B1 | PROCESS FOR PREPARING POLYMERS IN THE PRESENCE OF TRIAZOLYL RADICALS | BASF AG (DE) | 2001-05-02 | — | — | EP | disclosed |
| US-6218468-B1 | CARRIED OUT IN THE PRESENCE OF FROZEN MICELLES OF AMPHIPHILIC SUBSTANCES. | BASF AKTIENGESELLSCHAFT (DE) | 2001-04-17 | — | — | US | disclosed |
| EP-1068244-A1 | METHOD FOR PRODUCING COPOLYMERS FROM FUNCTIONALISED OLEFINICALLY UNSATURATED MONOMERS AND NON-POLAR OLEFINICALLY UNSATURATED COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2001-01-17 | — | — | EP | disclosed |
| EP-0876413-B1 | POLYMERS SUITABLE AS DISPERSING RESINS | BASF AG (DE) | 2000-04-12 | — | — | EP | disclosed |
| US-6008303-A | Polymers suitable as dispersing resins | BASF AKTIENGESELLSCHAFT (DE) | 1999-12-28 | — | — | US | disclosed |
| WO-1999047569-A1 | METHOD FOR PRODUCING COPOLYMERS FROM FUNCTIONALISED OLEFINICALLY UNSATURATED MONOMERS AND NON-POLAR OLEFINICALLY UNSATURATED COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1999-09-23 | — | — | WO | disclosed |
| EP-0876414-B1 | BLOCK COPOLYMERS | BASF AG (DE) | 1999-08-25 | — | — | EP | disclosed |
| EP-0876414-A1 | BLOCK COPOLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997027233-A1 | BLOCK COPOLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 1997-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171774-A1 | Polymerization-active transition metal complexes having bulky ligand systems | AP1M1, CCNC, CLTB | ALDH1A1 2788/4885BACE1 3662/4885HSD11B1 4246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.